Clinical Trial Design Agenda

All times are in GMT

12:25 pm - 12:30 pm PHARMA IQ WELCOME

  • How is the industry reacting to this shift in leveraging remote strategies?
  • How do we balance key factors such as patient centricity, data, regulation, compliance and cost, and should flexibility be the greatest priority?
  • What impact is this having on the regulators and how they operate?
  • Will remote trials affect data endpoints and to what extent?
  • What impact do virtual, decentralised and hybrid trials have on patients and how can we reduce potential burdens?
  • How is this influencing patient engagement strategies?
img

Kim Hawkins

Global Head CSO Project Leaders
Sanofi

img

Musaddiq Khan

Director, Clinical Program Operations
Eli Lilly

img

Fiona Maini BSc. MSc.

Principal Global Compliance and Strategy
Medidata Solutions a Dassault Systèmes Company

img

Rosamund Round

Vice President, Patient Innovation Center and Decentralized Trials
Parexel

1:30 pm - 2:10 pm VIRTUALISATION AND PATIENT CENTRED DESIGN: TECHNOLOGY AND THE FUTURE OF CLINICAL TRIALS

Paul O’Donohoe - Scientific Lead, eCOA and Mobile Health, Medidata Solutions a Dassault Systèmes Company
  • While clinical trials are getting ever more complex, the use of technology such as eCOA, wearables and “virtualisation” allows us to capture increasingly accurate data while mitigating the burden on patients
  • Putting patients at the heart of how we design clinical technologies ensures we’re building solution that work for patients and captures the data needed to demonstrate safety and efficacy
  • The impact of the Covid-19 pandemic will accelerate trends that have been developing for years
img

Paul O’Donohoe

Scientific Lead, eCOA and Mobile Health
Medidata Solutions a Dassault Systèmes Company

2:10 pm - 2:50 pm CREATING A PATIENT-CENTRIC APPROACH THROUGH DIGITAL INNOVATION

Terttu Haring - Global Head for Clinical Digital Innovation, Sanofi
  • Enhancing integration, optimisation and digitisation in order to improve transparency and data sharing
  • Internal E2E Support: Providing the training, tools and technology to support your internal teams through each digital process
  • Understanding how to use intelligent automation and continuous patient data to provide real time monitoring, and enable efficient data driven decisions
img

Terttu Haring

Global Head for Clinical Digital Innovation
Sanofi

2:50 pm - 3:20 pm CONTENT BREAK

  • Ensuring the patient voice is heard throughout the lifecycle of a trial to guarantee better study delivery for patient benefit
  • Leveraging AI to improve patient recruitment and enabling real-time clinical trial matching based clinical data at the point of care
  • How is the ongoing pandemic affecting patient relations and patient diversity?
img

Gareth Powell

Business Development Officer and Patient Engagement Project Lead
NIHR Clinical Research Network

  • A brief history of barriers and the current state of diversity in clinical trials
  • Inclusive Design: Are your trials reflective of the patient population they aim to serve?
  • How can trials be more reflective of populations with disease?
  • How can we increase education and awareness to avoid patient bias and improve recruitment?
  • What are some other approaches to overcome barriers and extend the reach of trials to more diverse participants?
img

Elizabeth George

Director, Clinical Trials Diversity
GSK

img

Keri Mcdonough

Lead, Advocacy and Patient Relations
Syneos Health Communications

img

Poonam Pattni

Senior Associate, Global Clinical Trial Disclosure
Eisai

5:00 pm - 5:00 pm CLOSE OF WEBINAR